Evidence map›Paper›PMID 25732820›Full record

ArticleCell reports2015

Human C6orf211 encodes Armt1, a protein carboxyl methyltransferase that targets PCNA and is linked to the DNA damage response.

J Jefferson P Perry, Gregory D Ballard, Alexandra E Albert, Lacey E Dobrolecki, Linda H Malkas, Derek J Hoelz

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Leg length and bristle density, both necessary for water surface locomotion, are genetically correlated in water striders.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

J Jefferson P PerryDepartment of Biochemistry, University of California, Riverside, Riverside, CA 92521, USA; School of Biotechnology, Amrita University, Kollam, Kerala 690525, India.
Gregory D BallardMaine Institute for Human Genetics and Health, Bangor, ME 04401, USA.
Alexandra E AlbertMaine Institute for Human Genetics and Health, Bangor, ME 04401, USA.
Lacey E DobroleckiDepartment of Hematology and Oncology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Linda H MalkasDepartment of Hematology and Oncology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Derek J HoelzMaine Institute for Human Genetics and Health, Bangor, ME 04401, USA; Department of Hematology and Oncology, Indiana University School of Medicine, Indianapolis, IN 46202, USA. Electronic address: hoelzd@husson.edu.
Indiana University – Purdue University Indianapolis · USIndiana University School of MedicineUniversity of California, Riverside · US

Funding

A Structure/function Analysis of a Tumor Specific ProteinR01CA121289 · NCI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI MALKAS, LINDA H. · 2007 to 2011
$1.5M
Structural biochemistry studies on MAP kinase allosteric binding sitesR03AR059968 · NIAMS · SCRIPPS RESEARCH INSTITUTE, THE · PI PERRY, JOHN JEFFERSON · 2011 to 2013
$280k
NCI NIH HHS 5R01CA121289-03NCI NIH HHS R01 CA121289NIAMS NIH HHS AR059968-03NIAMS NIH HHS R03 AR059968
6 · The paper itself

Abstract

Recent evidence supports the presence of an L-glutamyl methyltransferase(s) in eukaryotic cells, but this enzyme class has been defined only in certain prokaryotic species. Here, we characterize the human C6orf211 gene product as "acidic residue methyltransferase-1" (Armt1), an enzyme that specifically targets proliferating cell nuclear antigen (PCNA) in breast cancer cells, predominately methylating glutamate side chains. Armt1 homologs share structural similarities with the SAM-dependent methyltransferases, and negative regulation of activity by automethylation indicates a means for cellular control. Notably, shRNA-based knockdown of Armt1 expression in two breast cancer cell lines altered survival in response to genotoxic stress. Increased sensitivity to UV, adriamycin, and MMS was observed in SK-Br-3 cells, while in contrast, increased resistance to these agents was observed in MCF7 cells. Together, these results lay the foundation for defining the mechanism by which this post-translational modification operates in the DNA damage response (DDR).

Indexed as

DNA RepairAmino Acid SequenceAnimalsCell Line, TumorDNA DamageHumansMCF-7 CellsMethylationMolecular Sequence DataProliferating Cell Nuclear AntigenProtein O-MethyltransferaseProtein Structure, TertiaryRNA InterferenceRNA, Small InterferingSequence AlignmentSubstrate SpecificityArmt1 protein, humanProliferating Cell Nuclear AntigenProtein O-MethyltransferaseRNA, Small Interfering

Identifiers

PMID25732820
PMCPMC4350021
OpenAlexW1988829747

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.